[en] Neonatal hyperthyroidism is a rare pathology, most often the consequence of Graves' disease in the mother. Around 0.2% of pregnant women have Graves disease and 1 to 2% of newborns of mother with Graves' disease. This article will describe the case of 4 newborns who have been diagnosed and treated in CHU-NDB between 2007 and 2011. The second part will focus on the new recommendations about the management of these young patients from foetal period to birth.
Disciplines :
Pédiatrie Endocrinologie, métabolisme & nutrition
Auteur, co-auteur :
PETIGNOT, Sandrine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'endocrinologie clinique
Fisher DA, Nelson JC, Carlton EI, et al. - Maturation of human hypothalamic-pituitary-thyroid function and control. Thyroid, 2000, 10, 229-234.
Vautier V, Moulin P, Guérin B, et al. - Transient neonatal thyrotoxicosis: clinical presentation and treatment in 7 cases. Arch Pediair, 2007, 14, 1310-1314.
McLachlan SM, Rapoport B. - Thyrotropin blocking autoantibodies and thyroid stimulating autoantibodies: insight into the pendulum from hypothyroidism to hyperthyroidism or vice versa. Thyroid, 2013, 23, 14-24.
Azizi F, Amouzegar A. - Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol, 2011, 164, 871-876.
Khalife A, Valdes-Socin H, Beckers A. - Controverses thé rapeutiques: le traitement de la maladie de Basedow. Rev Med Liege, 1999, 54, 606-610.
Prummel MF, Wiersinga WM. - Smoking and risk of Graves' disease. JAMA, 1993, 269, 479-482.
Valdes-Socin H, Vroonen L, Latta C, et al. - Le Tabac et ses effets sur le système endocrinien. Rev Med Liège, 2010, 65, 498-501.
Luton D, Le Gac I, Vuillard E, et al. - Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab, 2005, 90, 6093-6098.
Neale D, Burrow G. - Thyroid disease in pregnancy, 2004, 31, 893-905.
Momotani N, Noh JY, Ishikawa N, et al. - Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab, 1997, 82, 3633-3636.
Hackmon R, Blichowski M, Koren G. - The safety of methimazole and propylthiouracil in pregnancy: a systematic review. J Obstet Gynaecol Can, 2012, 34, 1077-1086.
Rosenfeld H, Ornoy A, Shechtman S, et al. - Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol, 2009, 68, 609-617.
Cooper DS. - Antithyroid drugs. N Engl J Med, 2005, 352, 905-917.
Malozowski S, Chiesa A. - Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more. Clin Endocrinol Metab, 2010, 95, 3161-3163.
Rivkees SA, Szarfman A. - Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab, 2010, 95, 3260-3267.
Performances médicales. - http://www.performancesmedicales.com/ JIRGO/crjirgol/lundi/article04.htm - Consultation du 30 février 2012
Sato H, Hattori M, Fujieda M, et al. - High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil. J Clin Endocrinol Metab, 2000, 85, 4270-4273.
Cooper DS, Rivkees SA. - Putting propylthiouracil in perspective. J Clin Endocrinol Metab, 2009, 94, 1881-1882.
Glatstein MM, Garcia-Boumissen F, Giglio N, et al. - Pharmacologic treatment of hyperthyroidism during lactation. Can Fam Physician, 2009, 55, 797-798.
Ranzini AC, Ananth CY Smulian JC, et al. - Ultrasonography of the fœtal thyroid: normograms based on biparietal diameter and gestationnal age. J Ultrasound Med, 2001, 20, 613-617.
